Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | ABSI | Common Stock | 6.36M | Jul 21, 2021 | Direct | ||||||
holding | ABSI | Common Stock | 2.27M | Jul 21, 2021 | See footnote | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | ABSI | Stock Option (right to buy) | Jul 21, 2021 | Common Stock | 21.9K | $1.10 | Direct | F2 | ||||||
holding | ABSI | Stock Option (right to buy) | Jul 21, 2021 | Common Stock | 2.69K | $1.10 | Direct | F3 | ||||||
holding | ABSI | Stock Option (right to buy) | Jul 21, 2021 | Common Stock | 397K | $1.21 | Direct | F4 | ||||||
holding | ABSI | Stock Option (right to buy) | Jul 21, 2021 | Common Stock | 127K | $1.10 | Direct | F4 | ||||||
holding | ABSI | Stock Option (right to buy) | Jul 21, 2021 | Common Stock | 8.51K | $1.10 | See footnote | F1, F2 | ||||||
holding | ABSI | Stock Option (right to buy) | Jul 21, 2021 | Common Stock | 1.04K | $1.10 | See footnote | F1, F3 |
Id | Content |
---|---|
F1 | These shares are held by Brittany McClain and are subject to a voting agreement and proxy pursuant to which the Reporting Person is entitled to vote such shares on all matters presented to the Issuer's stockholders for approval. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, if any. |
F2 | This option is fully vested and exercisable. |
F3 | 25% of the shares subject to this option vested and became exercisable on July 11, 2018, and thereafter, the remaining shares subject to this option vested and became exercisable in 36 approximately equal monthly installments until July 11, 2021, such that this option is fully vested and exercisable. |
F4 | The shares subject to this option vest and become exercisable in 48 approximately equal monthly installments from March 4, 2021 until March 4, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date. |